JP Morgan cuts Immunovant target price to $49 from $50
IMVT•JP Morgan cut its target price for Immunovant to $49 from $50.
Related News
Sionna Therapeutics presents plans for Phase 2 trial of cystic fibrosis drug combination
SION•
Ferguson Enterprises: Deutsche Bank raises target price to $273 from $235
FERG•
Ardelyx to participate in fireside chat at Jefferies Global Healthcare Conference
ARDX•
Oil falls as Trump downplays prospect of escalation with Iran
USO•
IIFL Finance says Blackstone to invest 50 billion rupees for about 16% stake
BX•